FitLife Brands (FTLF) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
FitLife Brands (FTLF) has outperformed Niagen Bioscience (NAGE) over the past year, losing 58.1% versus a loss of 64.2%. Over five years, FTLF leads with a +26.1% price change compared with -58.2% for NAGE. Niagen Bioscience is the larger company by market cap ($210.5 million vs $81.7 million), about 2.6 times the size.
On valuation, FitLife Brands trades at a lower forward P/E (6.7x vs 26.6x for Niagen Bioscience).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FTLF | NAGE |
|---|---|---|
| Share price | $8.70 | $2.66 |
| Market cap | $81.70M | $210.48M |
| 1-day change | -5.74% | -2.21% |
| YTD return | -46.53% | -58.18% |
| 1-year return | -58.09% | -64.20% |
| 5-year return | +26.09% | -58.18% |
| P/E ratio (TTM) | 14.03 | 14.00 |
| Forward P/E | 6.74 | 26.60 |
| EPS (TTM) | $0.62 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.98 | $7.95 |
| 52-week low | $8.51 | $2.61 |
| Distance from 52-week high | -58.53% | -66.54% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +101.15% | +354.14% |
| Average volume | 11.75K | 585.61K |
| Shares outstanding | 9.39M | 79.13M |
| Employees | 81 | 117 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Niagen Bioscience is about 2.6 times larger than FitLife Brands by market value ($210.48M vs $81.70M).
About FitLife Brands
FTLF stock →FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally.
Health Care · Medicinal Chemicals and Botanical Products · 81 employees
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
FTLF vs NAGE FAQ
Which is bigger, FitLife Brands or Niagen Bioscience?
Niagen Bioscience (NAGE) is larger, with a market capitalization of $210.48M compared with $81.70M for FitLife Brands (FTLF).
Which stock has performed better over the past year, FTLF or NAGE?
FTLF returned -58.09% over the past 12 months, compared with -64.20% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, FTLF or NAGE?
NAGE has the lower trailing P/E at 14.0, versus 14.0 for FTLF. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are FitLife Brands and Niagen Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.